TCRX$0.189+5.47%
TScan Therapeutics, Inc.
Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$12.81M
Float & O/S:
Inst Own:
DilutionScan read 29 of TScan Therapeutics, Inc.'s SEC filings and found 4 warrant series, 1 convertible, 1 ATM program and 4 shelf registrations on file for TCRX. The latest dilution event on file is ATM sales on Aug 12, 2026. Analysis updated Oct 4, 2026.
